Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy

Abstract excerpt

Breast cancer (BC) is one of the most prevalent types of cancer worldwide with high morbidity and mortality rates. Treatment modalities include systemic therapy, in which chemotherapy is a major component in many cases. Several chemotherapeutic agents are used in combinations or as single agents with many adverse events occurring in variable frequencies. These events can be a significant barrier in completing the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer therapeutics and mechanisms
• Share to Cancer Treatment and Pharmacology
• Share to Pharmacogenetics and Drug Metabolism